Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Wafa Ben Sedrine"'
Autor:
Silvia M. A. A. Evers, Mickaël Hiligsmann, Véronique Rabenda, Olivier Bruyère, Wafa Ben Sedrine, Jean-Yves Reginster
Publikováno v:
European Journal of Public Health, 25(1), 20-25. Oxford University Press
Background: The supplementation with vitamin D and calcium has been recommended for elderly, specifically those with increased risk of fractures older than 65 years. This study aims to assess the cost-effectiveness of vitamin D and calcium supplement
Publikováno v:
Journal of Bone and Mineral Research, 28(4), 807-815. Wiley
Bazedoxifene is a novel selective estrogen receptor modulator (SERM) for the prevention and treatment of osteoporosis. In addition to the therapeutic value of a new agent, evaluation of the cost-effectiveness compared with relevant alternative treatm
Autor:
Jean-Yves Reginster, Carmen D. Dirksen, Wafa Ben Sedrine, Annelies Boonen, Mickaël Hiligsmann
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research, 13(1), 19-28. Routledge/Taylor & Francis Group
Denosumab is a novel biological agent for the treatment of osteoporosis in postmenopausal women with increased risk of fractures. With limited healthcare resources, economic evaluations are increasingly being used by decision-makers to optimize healt
Autor:
Wafa Ben Sedrine, Stuart G. Silverman, Mickaël Hiligsmann, Caroline E. Wyers, Jean-Yves Reginster, John A. Kanis, Bram Ramaekers, Silvia M. A. A. Evers, Annelies Boonen
Publikováno v:
Pharmacoeconomics, 33(3), 205-224. Adis International Ltd
Background Given the limited availability of healthcare resources and the recent introduction of new anti-osteoporosis drugs, the interest in the cost effectiveness of drugs in postmenopausal osteoporosis remains and even increases. Objective This st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca2fc2c94cd56a1cdc14b1193b64ce78
https://cris.maastrichtuniversity.nl/en/publications/e22cbb71-e5d4-47e2-b6ea-afccb9b8a081
https://cris.maastrichtuniversity.nl/en/publications/e22cbb71-e5d4-47e2-b6ea-afccb9b8a081
Autor:
Jean-Yves Reginster, Olivier Ethgen, Wafa Ben Sedrine, Jean-Marc Kaufman, Stefan Goemaere, Geneviève Depresseux, Jean-Pierre Devogelaer
Publikováno v:
Aging Clinical and Experimental Research. 16:413-419
Background and aims: The Belgian Social Security Institute (hereafter INAMI) proposes a list of conditions to be considered as a prerequisite for reimbursement of Bone Mineral Density (BMD) measurements. The aim of this paper was to evaluate the diag
Publikováno v:
Osteoporosis International. 14:716-721
Osteoporosis is a growing problem in Asia, and early identification of at risk subjects for preventive measures is likely the most cost-effective method for managing this disease in developing countries. Patients with low bone mineral density (BMD) h
Autor:
M. C. Micheletti, Jean-Yves Reginster, Brigitte Zegels, Angela Kvasz, Wafa Ben Sedrine, T. Chevallier, B Gelas
Publikováno v:
Gynecological Endocrinology. 16:245-250
A simple questionnaire would be useful to identify individuals most in need of bone mineral density (BMD) testing. We designed a new predictive model and risk assessment instrument based on an extensive review of the literature evaluating risk factor
Autor:
Olivier Ethgen, Wafa Ben Sedrine, Jean-Yves Reginster, Christiane Gosset, J De Maeseneer, V. Tellier
Publikováno v:
Bone. 32(6)
The objective was to quantify the outcome of osteoporosis (OP) in terms of health-related quality of life (HR-QOL) and cost of ambulatory care and to look at the association between these two outcomes variables. A cross-sectional health survey of 480
Autor:
Rajata Rajatanavin, Keh-Sung Tsai, Wafa Ben Sedrine, H M Park, Annie W.C. Kung, L Koh, Q R Huang, Jean-Yves Reginster, Tito P. Torralba, S P Chan, S Fujiwara
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 12(8)
Patients with low bone mineral density (BMD) have a high risk of future fractures, and should be actively considered for treatment to reduce their risk. However, BMD measurements are not widely available in some communities, because of cost and lack
Autor:
Jean-Yves Reginster, Wafa Ben Sedrine
Publikováno v:
Mayo Clinic Proceedings. 77:622-623